Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Understanding the relationship between GLP-1 medications and metabolic function helps explain why this connection is so strong
We are here to help you navigate the plateaus and the wins with equal empathy and expertise
Semaglutide (Ozempic) is PBS listed in Australia for the treatment of T2D but used off-label for weight loss on an unprecedented scale, while newcomer tirzepatide (Mounjaro) was approved by the TGA last year for patients with T2D, but has so far not been listed on the PBS
Compounded semaglutide ranges from $349/month on a one-month plan down to $174/month on a 12-month plan, and compounded tirzepatide ranges from $449/month on a one-month plan down to $283/month on a 12-month plan
US$ 28.02
US$ 28.47
US$ 28.71
US$ 24.07
US$ 25.13
US$ 21.64
US$ 20.76
